BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17664243)

  • 1. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
    Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
    Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance.
    Usui M; Yamaguchi S; Tanji Y; Tominaga R; Ishigaki Y; Fukumoto M; Katagiri H; Mori K; Oka Y; Ishihara H
    Metabolism; 2012 Aug; 61(8):1118-28. PubMed ID: 22386934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease.
    Chen Q; Jiang Y; An Y; Zhao N; Zhao Y; Yu C
    Biochem Biophys Res Commun; 2011 Jun; 409(4):651-6. PubMed ID: 21616061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet.
    Choi JS; Kim H; Jung MH; Hong S; Song J
    Mol Nutr Food Res; 2010 Jul; 54(7):1004-13. PubMed ID: 20112296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.
    Kaneko H; Anzai T; Nagai T; Anzai A; Takahashi T; Mano Y; Morimoto K; Maekawa Y; Itoh H; Yoshikawa T; Ogawa S; Fukuda K
    Cardiovasc Res; 2011 Aug; 91(3):546-55. PubMed ID: 21447704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
    Poggi M; Engel D; Christ A; Beckers L; Wijnands E; Boon L; Driessen A; Cleutjens J; Weber C; Gerdes N; Lutgens E
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2251-60. PubMed ID: 21817098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
    Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.
    Bjursell M; Admyre T; Göransson M; Marley AE; Smith DM; Oscarsson J; Bohlooly-Y M
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E211-20. PubMed ID: 20959533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice.
    Mercader J; Ribot J; Murano I; Feddersen S; Cinti S; Madsen L; Kristiansen K; Bonet ML; Palou A
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E184-93. PubMed ID: 19417128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term high-fat diet links the regulation of the insulin-sensitizing fibroblast growth factor-21 and visfatin.
    Sun B; Yang G; Yang M; Liu H; Boden G; Li L
    Cytokine; 2012 Jul; 59(1):131-7. PubMed ID: 22542568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet.
    Cha DR; Han JY; Su DM; Zhang Y; Fan X; Breyer MD; Guan Y
    Am J Nephrol; 2007; 27(5):479-82. PubMed ID: 17652964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
    J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E; Wood JA; Stanojevic V; Habener JF
    Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
    Bouter B; Geary N; Langhans W; Asarian L
    Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.
    Li JZ; Ye J; Xue B; Qi J; Zhang J; Zhou Z; Li Q; Wen Z; Li P
    Diabetes; 2007 Oct; 56(10):2523-32. PubMed ID: 17646209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.
    Santos SH; Fernandes LR; Mario EG; Ferreira AV; Pôrto LC; Alvarez-Leite JI; Botion LM; Bader M; Alenina N; Santos RA
    Diabetes; 2008 Feb; 57(2):340-7. PubMed ID: 18025412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.